関連ニュース

Dolby Laboratories is rated Buy due to its high margins, robust buyback program, and undervalued share price despite weak growth. DLB's 90% gross margin and operating leverage enable EPS growth even w

Innovation Passport award designed to support accelerated time to market and help expedite patient access to potentially transformative new investigational medicines

NetEase, Tencent Music Entertainment Group, Dolby Laboratories, Warner Music Group, Madison Square Garden Entertainment, Zeta Network Group, and Reservoir Media are the seven Music stocks to watch tod

Dolby Laboratories is now undervalued after a 50%+ decline from its all-time high, trading at 18.7x FCF and 19.7x earnings. DLB's revenue growth remains choppy, but licensing—especially in Broadcast a